home / stock / xgn / xgn news

XGN News and Press, Exagen Inc. From 11/09/23

Stock Information
Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NYSE
Website: exagen.com
Menu
XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...
XGN - Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers

SAN DIEGO, California, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced today the execution of an exclusive license agreement. Exagen will focus on the development of novel pat...
XGN - Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SAN DIEGO, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, which takes place Novembe...

XGN - Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2023, after the market close on Monday, November 13, 2023. John Aballi, Exagen’s Presiden...

XGN - Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting

SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2023, bei...
XGN - Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, which takes place September 26-28, 2023, at the InterCon...

XGN - Exagen Inc. (XGN) Q2 2023 Earnings Call Transcript

2023-08-07 13:42:05 ET Start Time: 08:30 End Time: 09:21 Exagen Inc. (XGN) Q2 2023 Earnings Conference Call August 07, 2023, 08:30 AM ET Company Participants John Aballi - President and CEO Kamal Adawi - CFO Ryan Douglas - IR Conference Call Partici...

XGN - Exagen beats Q2 top and bottom line estimates; initiates Q3 outlook

2023-08-07 08:09:44 ET Exagen press release ( NASDAQ: XGN ): Q2 GAAP EPS of -$0.28 beats by $0.21 . Revenue of $14.14M (+85.8% Y/Y) beats by $3.21M . Cash and cash equivalents were $31.5 million as of June 30, 2023, which reflects the $10 million principal...
XGN - Exagen Inc. Reports Strong Second Quarter 2023 Results

SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2023. Second Quarter Highlights: Delivered a record 37,749 AVISE® CTD tests in ...

XGN - Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference

SAN DIEGO, July 26, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 43 rd Annual Growth Conference, which takes place August 7-10, 2023, at the InterContinental B...

XGN - Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023

SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2023, before the market open on Monday, August 7, 2023. John Aballi, Exagen’s President and Ch...
Previous 10 Next 10